Browse By: Country ι Category ι Latest Reports ι Tag

Medical Tourism Market (India, Thailand, Singapore, Malaysia, Mexico, Brazil, Taiwan, Turkey, South Korea, Costa Rica, Poland, Dubai and Philippines) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Pages » 139
Published By » Transparency
Price » $4795
In stock
View Report Details
Description

Rise in healthcare costs in developed countries coupled with the availability of high quality medical services at lower prices in developing nations has primarily surged the expansion of the medical tourism industry. Moreover, rise in elderly population along with growing number of uninsured population has further triggered the market growth. Patients are travelling abroad not only for cosmetic surgeries with a quick recovery, but also for sophisticated cardiovascular surgeries. Many countries plan to leverage medical tourism as a strategy to boost their healthcare services and tourism industry. By encouraging its presence in the medical tourism market, a country can stimulate its economic... Click here for more details


Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
GBI Research’s report, “Sales Force  Effectiveness in Pharmaceuticals - Cost Pressures Increases Pharmaceutical Companies\' Adoption of New Sales Models and Technologies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes t
Published Date: Oct 2010
Price: $3500
Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns
GBI Research, the leading business intelligence provider, has released its latest report, “Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns” that provides key data, information and analysis of the major tre
Published Date: Oct 2010
Price: $3500
Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
GBI Research’s medical devices report, “Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers” provides key data, information and analysis on the pharmaceutical analytical services outsourcing in in
Published Date: Nov 2010
Price: $3500
Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets
GBI Research’s new report, “Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets”, provides in-depth analysis of various patent protection strategies adopted by pharmaceutical companies for maximizing revenues re
Published Date: Dec 2010
Price: $3500
Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market
GBI Research, a leading business intelligence provider, has released its latest research, “Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market”. The report provides in-depth analysis of the unmet needs, drivers and barriers
Published Date: Dec 2010
Price: $3500
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
GBI Researchs new report, Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategie
Published Date: Jan 2011
Price: $3500
Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth
GBI Research has released its pharmaceutical report, Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth that provides key data, information and analysis of the major trends and issues affecting the clinical trial market
Published Date: Apr 2011
Price: $3500
Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market
GBI Research, the leading business intelligence provider, has released its latest research Sleep Disorders Market to 2017- Generics Substitution Coupled with a Weak Pipeline Will Negatively Impact the Market, which provides insights into sleep disorders therapeutics sales and price forecasts u
Published Date: Apr 2011
Price: $3500
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
GBI Research has released its research, Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost, which provides insights into recruitment strategies, challenges and solutions for on-
Published Date: May 2011
Price: $3500
ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders
GBI Researchs pharmaceutical report, ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders provides in-depth analysis of unmet needs, drivers and barriers that impact the global ENT disorders market. The report ana
Published Date: Apr 2011
Price: $3500

 


 

Related News

Upfront Payout of US$65 Million for Isis Pharma
Isis Pharmaceuticals continues to expand into multiple disease sectors, in which the latest move includes the signing of a top level drug development partnership with another drug company. The new partnership with AstraZeneca will get US$65 million to Carlsbad biotech upfront. The deal also calls for Isis Pharma to discover and work on drugs that are useful in cardiovascular, kidney, and metabolic diseases. They are to develop these drugs using the antisense technology developed by Isis. I
Date: Aug 03

16.59% Rally of China Pharma Holdings’ Shares
China Pharma Holdings, Inc. company shares rose by 16.59% in the previous week. The pharma company still tallied to a loss of 23.53% during the past four weeks. The company share did surpass the S&P 500 in the previous week by 15.25%. However, they have underperformed the index by 24.51% within the last four weeks. China Pharma Holdings, Inc. shares have slowed down by 29.73% within the previous three month period. The current year-on-year performance is -13.36%. The company shares
Date: Aug 03

Japan Promotes Higher Education to Improve the Skills of the Graduates
Shinzo Abe, the Prime Minister of Japan, is aiming to develop better-skilled graduates by retooling the public universities. The main motto is to transform the government-funded universities of Japan into scientific research centers, schools or global leaders. Japan’s Universities are planning to achieve this target by restructuring the curricula and redefining the missions. In June, all 86 of Japan’s national level universities were asked to submit their refined plans by the educ
Date: Aug 03

Hong Kong Ranked Fourth Amongst the 148 Most Popular Arbitral Venues
Cross-border investments, in the recent past, led to complex relations amongst the commercial parties. Commercial parties are moreover depending on the international arbitration to solve respective disputes. Hong Kong, for many reasons, is considered to be the most attractive arbitral venue in Asia Pacific.  As per the World Economic Forum Global Competitiveness Report, published for year 2013-2014, Hong Kong is ranked fourth amongst the 148 jurisdictions. Hong Kong is supposedly ahead o
Date: Aug 03

Slump in Oil and Gas Industry Taking Toll on Industry Economy
As the shippers, drivers, and airlines maintain to enjoy the lower fuel prices, the oil industry is broadly responding to extremely lower profits with high cuts in employment and spending. These cuts are affecting the economic growth.    Low gas and oil prices are beneficial for the overall economy. They help to reduce the costs for business and consumers. As the U.S. economic growth was extremely higher in the second quarter, the economists express that was partially boosted by the
Date: Aug 03

JX Holdings’ Sets its Summer Agenda toward Uproar in Oil Industry
The competition between companies in the global market is becoming more and more intense, day by day. The competition is growing both in domestic and overseas markets.  Yomiuri Shimbun, staff writer requested new leaders about their agenda for this summer. These leaders who took office at the top of the various companies this year were informed about the same.  Of all the companies, the star performer has reached the top and taken the stage. President Yukio Uchida, JX Holdings In
Date: Aug 03

HSBC Reports 10% Increase in Profit for 1st Half of 2015
HSBC Holdings has reported a rise in its profit for the first-half of 2015 by 10%. In a press note issued of Aug 03, 2015, the biggest bank in Europe has stated that the robust performance has helped the company to boost its revenue. In the same note, the bank has also announced the sale of its Brazilian unit for US$5.2 billion. The profit for H1 of 2015 has increased to 48 cents per share, summing up to US$13.6 billion in a whole, stated the bank. The revenue of the bank has increased by 4%
Date: Aug 03

China Plan to Tighten Regulations to Control Online Payment
China has plans to tighten the regulations that governs the country’s 270 online-payment enterprises such as Alibaba. This move has come as another blow to the flourishing Internet business for finance. Under the draft rules issued on July 31, 2015, the central bank is likely to limit the amount that a person can pay online through a third-party payment account to US$805 per day, crossing which, the customer would need to verify his/her identity via an electronic signature and security
Date: Aug 03

Walmart to Further Invest in E-commerce Business in China
The e-commerce market of China has not been a very easy one for Walmart to crack into, however the American retail giant is in no way giving in. On the contrary, Walmart has begun investing a lot more towards the e-commerce operations that it had initiated there, and in a way has taken total control of a particular China-based online retailer.  Walmart, on Thursday ended up purchasing the leftover shares of the Chinese company called Yihaodian. This was after it was seen that Walmart was
Date: Jul 31

Inflatable Device to Help Obese Patients Lose Weight gets FDA Approval
The United States Food and Drug Administration has given its approval for an inflatable device that can help patients suffering from obesity shed their weight without any surgeries. The balloon, made by Reshape Medical, will be inserted inside the body and fill a portion of the stomach.  A minimally invasive endoscopic procedure will be performed by doctors, where in they will go in through the mouth to reach the stomach and implant the device. Typically, the procedure will take less tha
Date: Jul 31

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency
Price: $4795